VNDA
NASDAQ · Biotechnology
Vanda Pharmaceuticals Inc
$5.00
-0.12 (-2.25%)
Open$5.16
Previous Close$5.12
Day High$5.17
Day Low$4.97
52W High$9.94
52W Low$4.14
Volume—
Avg Volume988.0K
Market Cap299.95M
P/E Ratio—
EPS$-4.05
SectorBiotechnology
Analyst Ratings
Strong Buy
10 analysts
Price Target
+209.0% upside
Current
$5.00
$5.00
Target
$15.45
$15.45
$11.33
$15.45 avg
$18.37
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 215.67M | 227.72M | 122.09M |
| Net Income | -220,038,103 | -209,095,441 | 12.67M |
| Profit Margin | -102.0% | -96.9% | 10.4% |
| EBITDA | -143,874,913 | -144,315,454 | 21.61M |
| Free Cash Flow | — | — | 20.08M |
| Rev Growth | -5.3% | -5.3% | +22.8% |
| Debt/Equity | 0.02 | 0.02 | 0.48 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $246.04 | +0.89% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $410.95 | +1.51% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $133.21 | +1.80% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $496.07 | +2.49% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $784.36 | +1.59% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $219.20 | +1.43% | 35.2 | 28.41B |